The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma

The status of Fas and Fas ligand (Fas L) expression was investigated in this study for 103 hepatocellular carcinomas (HCC). We studied the expression of the following three factors, Fas and Fas L expression in carcinoma cells and Fas L expression in stromal mononuclear cells (defined as stromal Fas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Y, Monden, M, Takeda, T, Eguchi, H, Umeshita, K, Nagano, H, Nakamori, S, Dono, K, Sakon, M, Nakamura, M, Tsujimoto, M, Nakahara, M, Nakao, K, Yokosaki, Y, Matsuura, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363358/
https://www.ncbi.nlm.nih.gov/pubmed/10735508
http://dx.doi.org/10.1054/bjoc.1999.1065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363358/
https://www.ncbi.nlm.nih.gov/pubmed/10735508
http://dx.doi.org/10.1054/bjoc.1999.1065

Ejemplares similares